Publication Date: 2020-12-23
Practice Area: Corporate Entities
Industry: Distribution and Wholesale | Investments and Investment Advisory | Pharmaceuticals
Court: Delaware Supreme Court
Judge: Justice Traynor
Attorneys: For plaintiff: Stephen C. Norman, Jennifer C. Wasson, Tyler J. Leavengood, Potter Anderson & Corroon LLP, Wilmington, DE; Michael D. Blanchard, Amelia G. Pennington, Morgan, Lewis & Bockius LLP, Boston, MA for appellant.
for defendant: Samuel L. Closic, Eric J. Juray, Prickett, Jones & Elliott, P.A., Wilmington, DE; Gregory V. Varallo, Bernstein Litowitz Berger & Grossman LLP, Wilmington, DE; Eric L. Zagar, Michael C. Wagner, Christopher M. Windover, Kessler Topaz Meltzer & Check, LLP, Radnor, PA; Frank R. Schirripa, Daniel B. Rehns, Hillary Nappi, Hach Rose Schirripa & Cheverie LLP, New York, NY; David Wales, Andrew Blumberg, Bernstein Litowitz Berger & Grossmann LLP, New York, NY for appellees.
Case Number: D69232
Stockholders could file inspection demand after asserting credible circumstantial evidence that corporate directors and managers had engaged in wrongdoing.